Psoriatic exacerbation associated with insulin therapy.
Moore
Allan F
AF
Soper
Tiffany
T
Jones
Natalie
N
Grevelink
Joop
J
Abourizk
Nicolas
N
D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D018450:Disease Progression; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D008687:Metformin / Q000627:therapeutic use; D008875:Middle Aged; D011565:Psoriasis / Q000503:physiopathology*
D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine; D008687:Metformin